DOI:
10.1055/s-00050098
Journal of Coloproctology
LinksClose Window
References
Côté JF, Kirzin S, Kramar A. et al.
UGT1A1 polymorphism can predict hematologic toxicity in patients treated with irinotecan.
Clin Cancer Res 2007;
13 (11) 3269-3275
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.